Close

Roth Capital Reiterates Regeneron (REGN) at 'Buy' Following New Teva Pharma Ffasinumab Partnership

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. IBM
4. HCP
5. PI
6. BSX
7. LRCX
8. BA
9. BIIB
10. F


Go back to Roth Capital Reiterates Regeneron (REGN) at 'Buy' Following New Teva Pharma Ffasinumab Partnership
Regeneron (NASDAQ: REGN) Delayed: 906.54 --0 (-0%)
Previous Close $906.54    52 Week High $592.36 
Open $906.54    52 Week Low $325.35 
Day High $906.54    P/E 237.94 
Day Low $906.54    EPS $3.81 
Volume 11